Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
tirzepatide
Pharma
FDA removes Lilly's Mounjaro and Zepbound from its shortage list
Eli Lilly’s tirzepatide has been erased from the FDA’s shortage list, freeing Lilly from competing with compounders that have been making copycats.
Kevin Dunleavy
Oct 3, 2024 11:22am
Lilly markets single-dose Zepbound vials at a major price cut
Aug 27, 2024 11:14am
Lilly unveils diabetes prevention data for star drug tirzepatide
Aug 20, 2024 9:35am
Lilly's Mounjaro, Zepbound off the FDA shortage list
Aug 5, 2024 10:57am
Eli Lilly eyes tirzepatide cardio filings after late-stage win
Aug 1, 2024 10:01am
Lilly's Mounjaro triggers more weight loss than Novo rival: study
Jul 8, 2024 5:44pm
